15468604

Source:http://linkedlifedata.com/resource/pubmed/id/15468604

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0039421, umls-concept:C0220825, umls-concept:C1704426
pubmed:issue	4
pubmed:dateCreated	2004-10-7
pubmed:abstractText	ABT-510 is a small peptide thrombospondin-1 mimetic angiogenesis inhibitor under development by Abbott Laboratories for the potential treatment of solid tumors. ABT-510 is undergoing phase II clinical trials.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100891485
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides, http://linkedlifedata.com/resource/pubmed/chemical/Thrombospondin 1
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1464-8431
pubmed:author	pubmed-author:WestphalJohan RJR
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	451-7
pubmed:dateRevised	2008-6-5
pubmed:meshHeading	pubmed-meshheading:15468604-Amino Acid Sequence, pubmed-meshheading:15468604-Angiogenesis Inhibitors, pubmed-meshheading:15468604-Animals, pubmed-meshheading:15468604-Antineoplastic Agents, pubmed-meshheading:15468604-Clinical Trials, Phase II as Topic, pubmed-meshheading:15468604-Humans, pubmed-meshheading:15468604-Mice, pubmed-meshheading:15468604-Oligopeptides, pubmed-meshheading:15468604-Thrombospondin 1
pubmed:year	2004
pubmed:articleTitle	Technology evaluation: ABT-510, Abbott.
pubmed:affiliation	Radboud University Medical Center, Department of Pathology, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. J.Westphal@obgyn.umcn.nl
pubmed:publicationType	Journal Article, Evaluation Studies